LPTX
Companies
NASDAQ
Leap Therapeutics, Inc.
Health Care
$0.39
-$2.49 (-86.65%)
Price Chart
Overview
About LPTX
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
Market Cap
$85.7M
Volume
4.6M
Avg. Volume
1.6M
P/E Ratio
-0.2196
Dividend Yield
0.00%
Employees
44.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.46
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LPTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$85.7M
Volume4.6M
P/E Ratio-0.22
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 26, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025